The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project

Valeria Sebri, Chiara Marzorati, Patrizia Dorangricchia, Dario Monzani, Roberto Grasso, Arsela Prelaj, Leonardo Provenzano, Laura Mazzeo, Andra Diana Dumitrascu, Jana Sonnek, Marlen Szewczyk, Iris Watermann, Francesco Trovò, Nina Dollis, Evangelos Sarris, Marina Chiara Garassino, Christine M. Bestvina, Alessandra Pedrocchi, Emilia Ambrosini, Sokol Kosta, Enriqueta Felip, Mireia Soleda, Aina Arbusà, José Rodríguez-Morató, Alessandro Nuara, Yonah Lourie, Melissa Fernández-Pinto, Alfonso Aguarón, Gabriella PravettoniCancer 2024 · DOI

TL;DR

This systematic review examines the effectiveness of patient decision aids (PDAs) in lung cancer consultations, finding they generally improve patient knowledge, reduce anxiety, and enhance decision-making. While no single PDA emerged as superior, the review highlights the importance of clear communication and patient involvement in treatment choices.

What Problem Does This Paper Address?

Lung cancer is a devastating diagnosis with complex treatment options. Patients often struggle to understand their disease, treatment modalities, and potential side effects, leading to anxiety and uncertainty. This lack of clear information can hinder effective decision-making and negatively impact their quality of life. The paper addresses the need for tools that can bridge this information gap and empower patients to actively participate in their care decisions. Specifically, it investigates how Patient Decision Aids (PDAs) are implemented and their impact on lung cancer patients during consultations.

Methods

The researchers conducted a systematic review following PRISMA guidelines. They searched three major databases (Embase, PubMed, and Scopus) for studies published up to July 1, 2022. The search terms included "lung cancer care," "non-small cell lung cancer," "decision aid," "patient decision aid," "shared decision making," and "NSCLC." They specifically included quantitative research studies that applied a PDA in a patient-clinician interaction, evaluated its impact on patient outcomes (like anxiety, coping, and depression), and involved lung cancer patients. Qualitative studies, reviews, and theoretical articles were excluded. The quality of the included studies was assessed using the Cochrane risk of bias tool.

Datasets

Not discussed in the paper. This paper is a systematic review of existing literature, not an empirical study that collected or analyzed new datasets.

Key Insights and Ideas

  • PDAs are generally beneficial: The review consistently shows that PDAs positively impact various aspects of the patient experience, from understanding their illness to feeling more confident in their choices.
  • No one-size-fits-all solution: While PDAs are effective, the review found no single type of PDA that stands out as universally superior. This suggests that the best approach might be tailored to individual patient needs and preferences.
  • Beyond just information: PDAs seem to work by not only providing information but also by fostering a sense of empowerment and facilitating a more collaborative decision-making process between patients and clinicians.
  • Anxiety reduction is a key win: A significant finding is the consistent reduction in patient anxiety after using PDAs, which is crucial given the high-stress nature of a lung cancer diagnosis.
  • The importance of communication: The review underscores that effective patient-clinician communication is a cornerstone for reducing decisional conflict and improving treatment adherence.

Key Results

The systematic review included 10 studies. The main outcomes observed were:

  • Decision-making: Nine studies demonstrated improvements in decision-making processes, including reduced decisional conflict, increased satisfaction, and better alignment with patient preferences.
  • Patient Knowledge: Six studies showed that PDAs improved patients' understanding of their disease characteristics and treatment options.
  • Anxiety: Two studies reported a decrease in patient anxiety after using PDAs.
  • Other Variables: Six studies reported improvements in other areas such as quality of life, cognitive function, information recall, and tool acceptability.

Limitations and Future Work

The authors acknowledge several limitations:

  • Database Scope: While three databases were used, a more comprehensive search might have captured additional relevant studies.
  • Timeframe: Focusing on a more recent timeframe could provide insights into the latest PDA tools.
  • Qualitative Data: The review primarily focused on quantitative studies; incorporating qualitative research could offer a richer understanding of patient perspectives.
  • Limited Novel Therapies: Only one study included PDAs for immunotherapy and targeted therapies, highlighting a gap given the evolving treatment landscape.

Future work suggested includes:

  • Utilizing alternative search strategies to explore a wider range of lung cancer-specific outcomes.
  • Engaging with experts in oncology, patient decision-making, and health communication to identify less accessible literature.
  • Developing guidelines for future research to promote patient-centered PDAs.
  • Conducting meta-analyses to better assess the effectiveness of PDAs.
  • Creating new PDAs that address novel treatment choices in lung cancer.

Summary updated

Abstract

Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.
BibTeX
@inproceedings{sebri2024impact,
  author = {Valeria Sebri and Chiara Marzorati and Patrizia Dorangricchia and Dario Monzani and Roberto Grasso and Arsela Prelaj and Leonardo Provenzano and Laura Mazzeo and Andra Diana Dumitrascu and Jana Sonnek and Marlen Szewczyk and Iris Watermann and Francesco Trovò and Nina Dollis and Evangelos Sarris and Marina Chiara Garassino and Christine M. Bestvina and Alessandra Pedrocchi and Emilia Ambrosini and Sokol Kosta and Enriqueta Felip and Mireia Soleda and Aina Arbusà and José Rodríguez-Morató and Alessandro Nuara and Yonah Lourie and Melissa Fernández-Pinto and Alfonso Aguarón and Gabriella Pravettoni},
  title = {{The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project}},
  booktitle = {Cancer},
  year = {2024},
  doi = {10.1002/cam4.7159},
}
Figure